Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-05-15
1993-07-20
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 21, A61K 3702, A61K 3512
Patent
active
052293653
ABSTRACT:
The disclosure relates to the stimulation of an endocrine cell, in particular a pancreatic cell or its precursor, to grow and divide upon exposure to a neurotrophic agent such as nerve growth factor, laminin or both.
REFERENCES:
Castano and Eisenbarth, Annu. Rev. Immunol. 8:647-679 (1990).
Schneyer and Humphreys-Beher, J. Oral. Pathol. 17:250-256 (1988).
Le Douarin, Cell 53:169-171 (1988).
Alpert et al., Cell 53:295-308 (1988).
Teitelman, Developmental Biology 142:368-379 (1990).
Ernfors et al., Neuron 5:511-526 (1990).
Yada, et al, Journal of Biological Chemistry 264:2455-2462 (1989).
Zawalich, et al., Endocrinology 125:2400-2406 (1989).
Santos and Rojas, FEBS Letters 249:411-417 (1989).
Edwards et al Cell, vol. 58, pp. 161-170 Jul. 14, 1989.
Levi-Montalcini, Science 237:1154-1162 (1987).
Polak Michel
Potter Huntington
Seilheimer Bernd
Koh Choon
President and Fellows of Harvard College
Wityshyn Michael G.
LandOfFree
Endocrine cell stimulation by neurotrophic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endocrine cell stimulation by neurotrophic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endocrine cell stimulation by neurotrophic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760516